Kent Huston, MD
Rheumatology · Kansas City, MONPI 1194739227
Payments from drug & device makers
Across 2 payments — averaging $651.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Consortium Of Independent Immunology Clinics, LLC$1K
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Consortium Of Independent Immunology Clinics, LLC | 2 | $1,304 |
How this compares
$1,304 in reported general payments places this provider in the 40th percentile of 134 rheumatology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 52 | $458,201 |
| EnbrelEtanercept | 16 | $230,104 |
| Cosentyx Sensoready PenSecukinumab | 17 | $204,710 |
| Enbrel SureclickEtanercept | 17 | $147,791 |
| Cimzia (2 Pack)Certolizumab Pegol | 22 | $126,701 |
| Xeljanz XrTofacitinib Citrate | 22 | $124,953 |
| Enbrel MiniEtanercept | 13 | $95,992 |
| Humira(Cf)Adalimumab | 13 | $88,540 |
| Orencia ClickjectAbatacept | 13 | $74,650 |
| Hydroxychloroquine Sulfate | 1,356 | $56,196 |
| OtezlaApremilast | 11 | $52,995 |
| MethotrexateMethotrexate Sodium | 733 | $20,772 |
| Leflunomide | 243 | $13,204 |
| Sulfasalazine DrSulfasalazine | 225 | $11,655 |
| Mycophenolate Mofetil | 119 | $11,517 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Kansas City
- John ErvinKansas City$18.7M
- Ghaith NoaisehKansas City$1.6M
- Tina ShahKansas City$1.2M
- Mark BoxKansas City$396K
- Thomas ScottKansas City$48K
- David JohnKansas City$3K
- Julian MagadanKansas City$3K
- David TrueSpringfield$15.8M
- Anne WinklerCarthage$1.6M
- Alfred KimSaint Louis$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.